Free‐water and BOLD imaging changes in Parkinson's disease patients chronically treated with a MAO‐B inhibitor

Rasagiline is a monoamine oxidase type B inhibitor that possesses no amphetamine‐like properties, and provides symptomatic relief in early and late stages of Parkinson's disease (PD). Data in animal models of PD suggest that chronic administration of rasagiline is associated with structural cha...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Hum Brain Mapp
Главные авторы: Burciu, Roxana G., Ofori, Edward, Shukla, Priyank, Pasternak, Ofer, Chung, Jae Woo, McFarland, Nikolaus R., Okun, Michael S., Vaillancourt, David E.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2016
Предметы:
Research Articles
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4945383/
https://ncbi.nlm.nih.gov/pubmed/27089850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.23213
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы